Castle Creek Biosciences Expands its Innovative Gene Therapy Platform for Rare Genetic Connective Tissue Disorders through Research Collaboration with Mayo Clinic

Castle Creek Biosciences, Inc. announces research collaboration with Mayo Clinic.

Article from PR Newswire

Amicus Therapeutics spins off genetic medicine unit in $600M SPAC deal

Amicus Therapeutics Inc., has unveiled plans to spinoff a “next-generation genetic medicine company” named Caritas Therapeutics.

Article from Philadelphia Business Journal

After 30 years in Chesterbrook, AmerisourceBergen opens new headquarters in Conshohocken

AmerisourceBergen Corp. has exited Chesterbrook and moved its new headquarters to Conshohocken.

Article from Philadelphia Business Journal

Philadelphia’s startup ecosystem climbs 15 spots into the top 30 worldwide, report says

Philadelphia’s startup scene is ranked amongst the best-performing in the world according to Startup Genome.

Article from Philadelphia Business Journal 

Can­cer gi­ant Roche splash­es in­to cell ther­a­py with $3B+ Adap­ti­m­mune deal for off-the-shelf drugs

Roche’s Genetech has signed a deal to partner with Adaptimmune on off-the-shelf T cell therapies.

Article from Endpoints News

Penn spinout led by veteran pharma execs emerges from stealth mode, raises $50M to advance gene-editing technology

Director of the University of Pennsylvania’s gene therapy program, Dr. James Wilson, has formed a company specializing in gene editing.

Article from Philadelphia Business Journal

Engineering CAR T Cells to Deliver Endogenous RNA Wakes Solid Tumors to Respond to Therapy

A new study from Penn Medicine demonstrates a naturally occurring RNA can activate the body’s own natural T cells to seek out cancer cells that may have escaped recognition by CAR T cells.

Article from Penn Medicine

Renovacor, Inc. Closes Its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange

Renovacor, Inc. will begin trading on the New York Stock Exchange under ticket symbols “RCOR” and “RCOR.WS”, respectively.

Article from Business Wire

Investments in Philadelphia startups are setting records. These investors think the boom is here to stay.

With the increase of private equity deals, angel investing, and venture capital raises, experts believe spending on startups will continue in the year 2022.

Article from Philadelphia Business Journal